Home » Topics » Regulatory

Regulatory
RSS

Duavee approved for vasomotor symptoms and preventing postmenopausal osteoporosis

Oct. 4, 2013

Jublia approved in Canada for the treatment of onychomycosis

Oct. 4, 2013

FDA grants accelerated approval of new indication for Perjeta

Oct. 2, 2013

FDA approves vortioxetine for major depressive disorder

Oct. 1, 2013

FDA approves Cimzia for treatment of active psoriatic arthritis

Oct. 1, 2013

Simeprevir obtains first approval in Japan

Sep. 27, 2013

First approval in Europe for Gilead Sciences' cobicistat

Sep. 26, 2013

Bayer receives Canadian approval for riociguat in thromboembolic pulmonary hypertension

Sep. 26, 2013

First approval for dual bronchodilator Ultibro inhalation capsules by Japanese MHLW

Sep. 20, 2013

Takeda obtains first approval for Oblean in Japan

Sep. 20, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026